Acciones HedgePath Pharmaceuticals Inc
Acciones
US42278K1025
Biotecnología e investigación médica
Directores | Puesto | Edad | Desde |
---|---|---|---|
Frank O'Donnell
CEO | Chief Executive Officer | 74 | 13/12/22 |
James McNulty
DFI | Director of Finance/CFO | 73 | 13/12/22 |
Amy M. McCord
LAW | General Counsel | - | 01/01/19 |
Administradores | Puesto | Edad | Desde |
---|---|---|---|
Frank O'Donnell
CEO | Chief Executive Officer | 74 | 13/12/22 |
Samuel Sears
BRD | Director/Board Member | 80 | 02/08/13 |
Ronald Osman
BRD | Director/Board Member | 78 | 23/08/23 |
Varia. 1 de ene. | Capi. | |
---|---|---|
+44,48 % | 54,04 mil M | |
+43,57 % | 41,96 mil M | |
-0,86 % | 41,92 mil M | |
-7,59 % | 28,35 mil M | |
+12,30 % | 26,35 mil M | |
-21,83 % | 19 mil M | |
+7,15 % | 13 mil M | |
+29,40 % | 12,28 mil M | |
+25,15 % | 12,19 mil M |